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agricultural and/or waged work. As women are also the primary
carers in the family, the impact of tuberculosis is severe for indi-
vidual families as for society in general.
Evidence of gender disparities from studies in collaboration
betweenKarolinska Institutet andHanoiMedical University aswell
as fromthe literature include that TBdisease in somecontexts could
inﬂuence possibilities to marry, to stay married and even so via
proxy, since in particular women in a family with TB disease would
face barriers to marriage. Married women with TB may be at risk
of divorce, of their husband taking a second wife, or of being sent
to their natal homes. In Pakistan, marriage prospects as perceived
by parents inﬂuence treatment taking among unmarried children.
Conclusions: Gender dynamics are thus key factors affecting the
risk of a person becoming infected and developing tuberculosis
as well as his or her access to health information, health-seeking
behaviour and treatment outcome. In addition, gender norms and
gender inequality inﬂuence coping capacities and the social conse-
quences of having tuberculosis.
Future research needs include: Population-based studies in mul-
tiple settings together with sentinel surveillance activities are
recommended togetunbiaseddataonTB incidenceandprevalence.
Semi-active case-identiﬁcation in target populations, acknowledg-
ing the devastating effects of the interaction between gender and
HIV, eg. TB screening linked to PMTCTMore basic science initiatives
to investigate sex differences in immune response to infection and
determinants of disease development and the link to sex speciﬁc
hormone levels
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Sex differences in antiretroviral therapy efﬁcacy
and toxicity
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The development of effective combination antiretroviral ther-
apy (ART) has transformed the management of HIV infection
over the past twenty years, yet many challenges remain. Globally
women comprise half of all people living with HIV, yet women
have been underrepresented in most clinical trials evaluating the
efﬁcacy and safety of ART. More recently several groups of inves-
tigators have designed and analyzed clinical trials with a goal of
evaluating sex difference in ART. These studies have suggested
differential rates of toxicity in women and men and some impor-
tant differences in response rates to standard treatments. This
presentation will review recent ﬁndings on sex differences in
the pharmacokinetics of protease inhibitors and non-nucleoside
reverse transcriptase inhibitors and highlight sex differences and
efﬁcacy from recent clinical trials. Finally research priorities in the
area of sex differences in HIV therapy will be suggested.
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Rickettsial diseases in Eastern Africa
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Rickettsial diseases have been described in Eastern Africa
for over 50 years. These include: epidemic typhus (Rickettsia
prowazekii), murine typhus, (Rickettsia typhi) and Mediterranean
spotted fever also known as Kenyan tick typhus (Rickettsia conorii
subsp. conorii). Contemporary reports describe these samediseases
in addition to new rickettsiae and rickettsial diseases utilizing sero-
logical and molecular techniques. Some of the new agents and
diseases include: Rickettsia felis (ﬂea-borne spotted fever), Rick-
ettsia felis-like organisms (e.g. Candidatus Rickettsia asemboensis),
Rickettsia africae (African tick-bite fever), Rickettsia africae vari-
ants (e.g. Rickettsia sp. AVR4), Rickettsia aeschlimanni (an unnamed
tick-borne rickettsiosis), Rickettsia sibirica subsp. mongolitimonae
(lymphangitis-associated rickettsiosis), Rickettsia conorii subsp.
israelensis (Israeli spotted fever) and Candidatus Rickettsia kulagini.
These reports indicate that individuals residing in and thosevisiting
Eastern Africa are at risk of various rickettsial diseases. Unfortu-
nately, the dearth of comprehensive studies of the prevalence and
distribution of these rickettsiae or the incidence of the particular
rickettsioses hinder development of proper mitigation strategies.
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Rickettsioses in Africa: A paradigm of new or
emerging infectious diseases
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Rickettsioses were considered 20 years ago as being rare dis-
eases with one species of Rickettsia transmitted by ticks, per
continent. Modern tools have been disrupting the perception of
the world of rickettsioses. The ﬁrst works were performed directly
on biting arthropods (ticks, ﬂeas, mites) that helped to identify a
number of microorganisms putatively involved in human diseases.
This difﬁculty to use classical tools for diagnosis in patients (such
as culture), prevented for a long time the identiﬁcation of human
cases. The development of molecular tools based on skin (biopsies
and swabs), and blood shows the huge frequency of rickettsioses.
In rural Asia, rickettsioses (scrub typhus and murine typhus) are
among the most frequent cause of unexplained prolonged fever.
In western and eastern Africa, rickettsioses (mainly R. felis) are the
